Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Buprenorphine for the management of opioid withdrawal

Esta versión no es la más reciente

ver la versión actual 21 febrero 2017

Información

DOI:
https://doi.org/10.1002/14651858.CD002025.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 18 octubre 2004see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Alcohol y drogas

Copyright:
  1. Copyright © 2006 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Linda Gowing

    Correspondencia a: Department of Clinical and Experimental Pharmacology, University of Adelaide, Adelaide, Australia

    [email protected]

  • Robert Ali

    Drug and Alcohol Services Council, Parkside, Australia

  • Jason M White

    Clinical & Experimental Pharmacology, University of Adelaide, Adelaide, Australia

Contributions of authors

Linda Gowing assessed each potentially relevant study according to identified inclusion and exclusion criteria. Inclusion and exclusion decisions were confirmed by discussion with co‐reviewers. Linda Gowing extracted key information from included studies and compiled a first draft of the review. Robert Ali and Jason White confirmed and commented on the review content.

Sources of support

Internal sources

  • Drug and Alcohol Services Council, South Australia, Australia.

External sources

  • Commonwealth Department of Health and Aged Care, Canberra, Australia.

Declarations of interest

None.

Acknowledgements

Dr Marc Auriacombe was contact editor for the review.

Dr Rajat Ray and Associate Professor Rolley E. Johnson provided additional information on studies included in the review (Nigam 1993; Cheskin 1994, respectively).

Dr Zhao Chengzheng and Dr Liang Jianhui translated and assisted with assessment of two studies considered for this review (He 1999; Jia 2001) that were published in Chinese.

Dr Hao Wei provided additonal information on the nature of WeiniCom, a Chinese herbal preparation that was the comparison treatment for Hao 2000.

Dr Leslie Amass provided information on ongoing studies (Ling & Amass 2004; Ling & Amass 2004b)

Version history

Published

Title

Stage

Authors

Version

2017 Feb 21

Buprenorphine for managing opioid withdrawal

Review

Linda Gowing, Robert Ali, Jason M White, Dalitso Mbewe

https://doi.org/10.1002/14651858.CD002025.pub5

2009 Jul 08

Buprenorphine for the management of opioid withdrawal

Review

Linda Gowing, Robert Ali, Jason M White

https://doi.org/10.1002/14651858.CD002025.pub4

2006 Apr 19

Buprenorphine for the management of opioid withdrawal

Review

Linda Gowing, Robert Ali, Jason M White

https://doi.org/10.1002/14651858.CD002025.pub3

2004 Oct 18

Buprenorphine for the management of opioid withdrawal

Review

Linda Gowing, Robert Ali, Jason M White

https://doi.org/10.1002/14651858.CD002025.pub2

2002 Apr 22

Buprenorphine for the management of opioid withdrawal

Review

Linda R. Gowing, Robert L Ali, Jason M White

https://doi.org/10.1002/14651858.CD002025

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.